• Conditions and diseases

  • Blood and immune system •
  • Cancer •
  • Cardiovascular •
  • Central nervous system •
  • Digestive system •
  • Ear and nose •
  • Endocrine, nutritional and metabolic •
  • Eye •
  • Gynaecology, pregnancy and birth •
  • Infectious diseases •
  • Injuries, accidents and wounds •
  • Mental health and behavioural conditions •
  • Mouth and dental •
  • Musculoskeletal •
  • Respiratory •
  • Skin •
  • Urogenital

• Public health

  • Accidents and injuries •
  • Alcohol •
  • Behaviour change •
  • Cancer •
  • Cardiovascular disease •
  • Child health •
  • Child social care •
  • Chronic illness •
  • Diabetes •
  • Drugs •
  • Environmental health •
  • Infectious diseases •
  • Maternal health •
  • Mental health •
  • Non-communicable diseases •
  • Obesity and diet •
  • Occupational health •
  • Older people •
  • Physical activity •
  • Sexual health •
  • Smoking and tobacco •
  • Transport •
  • Vaccine preventable diseases •
  • Working with and involving communities

• Treatments, Procedures and Devices

  • Bones and joint surgery •
  • Cardiovascular surgery •
  • Cardiovascular system drug treatments •
  • Clinical devices •
  • Diagnostic imaging •
  • Diagnostic procedures •
  • Digestive tract and other abdominal organs surgery •
  • Drug treatments •
  • Endocrine system and breast surgery •
  • Eye surgery •
  • Nervous system surgery •
  • Radiotherapy •
  • Screening •
  • Surgical procedures •
  • Therapeutic procedures •
  • Tissue and organ donation •
  • Urogenital surgery

• Guidance by type

  • Clinical Guidelines •
  • Technology appraisals •
  • Public health guidance •
  • Diagnostics guidance •
  • Interventional procedures guidance •
  • Medical technologies guidance •
  • Cancer service guidance •
  • Quality standards

• Guidance by date

  • View the guidance by date published

About NICE guidance Close

Navigation

• NICE guidance

• Find guidance
• NICE Pathways
• Latest guidance
• Guidance by type
• Guidance in development
• How guidance is produced
• NICE guidance research recommendations
• Guidance for patients and public
• Other publications
• Patient safety solutions pilot
• Quality standards

Atrial fibrillation - dronedarone

Dronedarone within its licensed indication for the treatment of atrial fibrillation

Status:	History
Expected date of issue:	August 2010
Referral date:	November 2008
Wave:	19
Process:	STA
Topic area: Cardiovascular

Project team | Schedule | Stakeholders | Key documents

 

NICE project team

Executive Lead:	Gillian Leng
Technical Lead:	Sally Gallaugher
Communications manager:	Tonya Gillis
Project manager:	Kate Moore
Evidence review group:	NHS Centre for Reviews & Dissemination and Centre for Health Economics â??York

Top

 

Provisional schedule

Closing date for invited submissions / evidence submission:	26 August 2009
1st appraisal committee meeting:	25 November 2009

Top

 

Consultees and commentators

Manufacturers/sponsors Sanofi Aventis (dronedarone) Patient/carer groups AntiCoagulation Europe (ACE) Arrhythmia Alliance (AFA Affiliated) Atrial Fibrillation Association (AFA) Stroke Association Grown Up Congenital Heart Patients Association Professional groups British Association of Stroke Physicians British Cardiovascular Intervention Society (BCIS) British Heart Foundation Heart Rhythm UK Primary Care Cardiovascular Society Royal College of Nursing Royal College of Physicians Cardiology Committee Society of Cardiothoracic Surgeons of Great Britain and Ireland Others Department of Health Hounslow PCT Welsh Assembly Government General Department of Health, Social Services and Public Safety for Northern Ireland Medicines and Healthcare products Regulatory Agency NHS Quality Improvement Scotland Comparator manufacturers None Relevant research groups Heart Failure Research Group, University of Glasgow Evidence Review Group NHS Centre for Reviews & Dissemination and Centre for Health Economics, York National Institute for Health Research Health Technology Assessment Programme Associated Guideline Groups National Collaborating Centre for Chronic Conditions Associated Public Health Groups None

Top

 

Key documents

Atrial fibrillation - dronedarone: final appraisal determination 16 July 2010 Atrial fibrillation - dronedarone: appraisal consultation document 2 30 March 2010 Atrial fibrillation - dronedarone: appraisal consultation document 24 December 2009 Atrial fibrillation and atrial flutter - dronedarone: final scope 03 July 2009 Atrial fibrillation and atrial flutter - dronedarone: final matrix of consultees and commentators 03 July 2009 Atrial fibrillation and atrial flutter - dronedarone: response to comments on the draft scope 03 July 2009 Atrial fibrillation and atrial flutter - dronedarone: response to comments on the provisional matrix 03 July 2009 Atrial fibrillation and atrial flutter - dronedarone: draft scope 03 July 2009 Atrial fibrillation and atrial flutter - dronedarone: provisional matrix of consultees and commentators - pre-referral 03 July 2009

This page was last updated: 23 August 2010